Theranexus (EPA:ALTHX) | WebDisclosure

PRESS RELEASE

published on 02/12/2026 at 18:00, 8 days 15 hours ago

THX Pharma organise un webinaire pour commenter son accord stratégique avec Biocodex
THX Pharma annonce un webinaire pour discuter de son accord avec Biocodex portant sur le développement de traitements pour les maladies neurologiques rares

Webinaire Accord Stratégique Maladies Neurologiques Rares THX Pharma Biocodex
PRESS RELEASE

published on 02/12/2026 at 18:00, 8 days 15 hours ago

THX Pharma to Host a Webinar to Discuss Its Strategic Agreement with Biocodex
THX Pharma to host webinar discussing strategic agreement with Biocodex, including licensing terms and development outlook. Webcast on February 17, 6:00 p.m. CET. More info at theranexus.com

Webinar Strategic Agreement Neurological Diseases THX Pharma Biocodex
BRIEF

published on 02/10/2026 at 18:05, 10 days 15 hours ago

Strategic Licensing Agreement for Rare Disease Treatments

Rare Diseases Strategic Agreement Licensing Deal THX Pharma Biocodex
BRIEF

published on 02/10/2026 at 18:05, 10 days 15 hours ago

Accord Stratégique entre THX Pharma et Biocodex pour trois Maladies Rares

Maladies Rares Accord De Licence THX Pharma Biocodex Batten-1 Et TX01
BRIEF

published on 02/10/2026 at 18:05, 10 days 15 hours ago

Accord de licence stratégique pour les traitements des maladies rares

Accord Stratégique Maladies Rares Accord De Licence THX Pharma Biocodex
BRIEF

published on 02/10/2026 at 18:05, 10 days 15 hours ago

Strategic agreement between THX Pharma and Biocodex for three rare diseases

Rare Diseases License Agreement THX Pharma Biocodex Batten-1 And TX01
PRESS RELEASE

published on 02/10/2026 at 18:00, 10 days 15 hours ago

THX Pharma and Biocodex announce a strategic licensing agreement covering three rare diseases
Biocodex acquires licenses from THX Pharma to develop Batten-1 globally and TX01 in US and Canada. Deal worth up to €173M includes milestone payments and double-digit royalties

Batten-1 Licenses TX01 THX Pharma Biocodex
PRESS RELEASE

published on 02/10/2026 at 18:00, 10 days 15 hours ago

THX Pharma et Biocodex annoncent un accord stratégique de licences dans trois maladies rares
Biocodex acquiert les licences mondiales de Batten-1 et de TX01 pour le traitement de maladies rares en collaboration avec THX Pharma. Accord stratégique pour le développement et la commercialisation

Maladies Rares Batten-1 TX01 THX Pharma Biocodex
BRIEF

published on 01/27/2026 at 18:05, 24 days 15 hours ago

Bilan semestriel du contrat de liquidité de Theranexus

Contrat De Liquidité PORTZAMPARC Bilan Financier Theranexus Actions THX Pharma
BRIEF

published on 01/27/2026 at 18:05, 24 days 15 hours ago

Theranexus Liquidity Contract Half-Year Review

Liquidity Contract PORTZAMPARC Financial Report Theranexus THX Pharma Actions

Published on 02/21/2026 at 00:45, 8 hours 58 minutes ago

Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 9 hours 13 minutes ago

Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:15, 10 hours 28 minutes ago

DigiPower X Announces Closing of Settlement
Published on 02/20/2026 at 23:00, 10 hours 43 minutes ago

Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 11 hours 26 minutes ago

Organto Foods Completes Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 02/20/2026 at 18:36, 15 hours 6 minutes ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 15 hours 11 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 15 hours 19 minutes ago

POS-Transaction in Own Shares
Published on 02/20/2026 at 18:00, 15 hours 42 minutes ago

Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 15 hours 42 minutes ago

Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

View all EQS

Published on 02/20/2026 at 19:29, 14 hours 13 minutes ago

SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 14 hours 13 minutes ago

SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 15 hours 43 minutes ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 15 hours 43 minutes ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 16 hours 8 minutes ago

CHIFFRE D'AFFAIRES 2025

View all LES ECHOS COMFI WIRE

News